Animal Milk Oligosaccharides Can Protect Pet’s Microbiome During Antibiotic Treatment | Business

EPALINGES, Switzerland–(BUSINESS WIRE)–Oct 6, 2021–

A trial has discovered that Animal Milk Oligosaccharides (A.M.O.s) manufactured by main Swiss biotech consultants Gnubiotics Sciences can assist stop the results of antibiotics on the intestine microbiome.

This press launch options multimedia. View the complete launch right here: https://www.businesswire.com/news/home/20211005006044/en/

(Photo: GNUBIOTICS)

The situation of the microbiome is crucial to the well being and wellbeing of all mammals, however using antibiotics can harm its delicate steadiness. This can have severe results on animal well being: latest research have discovered the alteration within the microbiome attributable to antibiotics can enhance the chance of colorectal most cancers in people.

In addition, there’s additionally the very actual downside of antibiotic resistance attributable to overuse for routine and preventative remedy. As the variety of pets has elevated exponentially throughout the ongoing pandemic – at the moment, greater than 85 million households in Europe have a minimum of one – antibiotic resistance is an growing concern.

However, there could possibly be assist in sight for animals and their homeowners. Headline information from a latest research carried out on the Division of Nutritional Sciences on the University of Illinois, Urbana Cham web page (UIUC) in collaboration with the College of Veterinary Medicine and Biomedical Sciences at Texas A&M University reveals A.M.O.s manufactured by Gnubiotics helped defend the microbiome of canine from the unfavourable results of the antibiotic metronidazole. The research of 12 beagles discovered the microbiome of the canine handled with Gnubiotics’ A.M.O. GNU-100 shortly recovered intestine micro organism – comparable to Faecalibacterium prausnitzii, Bacteroides and Prevotella.

In addition, vital teams of micro organism important to a wholesome intestine biome comparable to Bacteroides spp. and Prevotella spp. have been protected against the results of antibiotics within the canine handled with the A.M.O.s. What’s extra, the research reveals that the microbiome of the canine given GNU-100 quickly returned to the complete variety wanted for good intestine well being. However, the microbiomes of beagles within the research not given A.M.O. GNU-100 by no means returned to full variety – and thus full well being – throughout the 16-week research.

Leading vet and microbiome knowledgeable Dr. Jan Suchodolski, Dr. VetMed and Professor of Small Animal Internal Medicine at Texas A&M, stated: “The gut microbiome is important to the health and disease status of dogs and cats. Data from this study provides strong evidence not only on the negative impact of antibiotics on the gut microbiome but also that data-driven solutions such as GNU-100 enable a faster recovery and restoration of key commensals such as Bacteroides.”

Yemi Adesokan, CEO and CSO at Gnubiotics commented: “We are excited and humbled by this first of its kind data and the underlying science that further shows the protective and restorative effect of our A.M.O.s GNU-100 on gut microbiomes altered by antibiotics. We will continue to invest in clinical trials to understand additional beneficial effects of GNU-100 on pet microbiome health and disease.”

ABOUT GNUBIOTICS

Gnubiotics Sciences is a Swiss biotech firm with a rising pipeline of microbiome focused candidates designed for each animals and people. Beyond its pipeline, Gnubiotics has additionally developed REVELAbiome™, a proprietary ultra-high decision sequencing know-how that allows detection and quantitation of bacterial taxonomy as much as the pressure degree. To study extra, please go to www.gnubiotics.com or comply with us on LinkedIn @ www. https://www.linkedin.com/company/gnubiotics/.

View supply model on businesswire.com:https://www.businesswire.com/news/home/20211005006044/en/

CONTACT: Press:

Yemi Adesokan

CEO/CSO

[email protected]

KEYWORD: SWITZERLAND NETHERLANDS GERMANY EUROPE IRELAND SPAIN FRANCE UNITED KINGDOM

INDUSTRY KEYWORD: BIOTECHNOLOGY MANUFACTURING OTHER HEALTH HEALTH PETS OTHER SCIENCE RESEARCH OTHER MANUFACTURING CONSUMER SCIENCE VETERINARY

SOURCE: Gnubiotics Sciences

Copyright Business Wire 2021.

PUB: 10/06/2021 02:00 AM/DISC: 10/06/2021 02:02 AM

http://www.businesswire.com/news/home/20211005006044/en

Copyright Business Wire 2021.